Results 31 to 40 of about 38,029,237 (226)

Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome

open access: yesFrontiers in Endocrinology, 2023
BackgroundMultiple Endocrine Neoplasia type 1 is a rare genetic syndrome mainly caused by mutations of MEN1 gene and characterized by a combination of several endocrine and non-endocrine manifestations.
Laura Pierotti   +12 more
doaj   +1 more source

Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome

open access: yesClinics, 2012
OBJECTIVE: To evaluate whether germline variants of the succinate dehydrogenase genes might be phenotypic modifiers in patients with multiple endocrine neoplasia type 2.
Nikoletta Lendvai   +10 more
doaj   +1 more source

Multiple Endocrine Neoplasia Type 1 (MEN1): Loss of One MEN1 Allele in Tumors and Monohormonal Endocrine Cell Clusters But Not in Islet Hyperplasia of the Pancreas [PDF]

open access: yes, 2006
CONTEXT: The occurrence of multiple small pancreatic endocrine tumors in patients suffering from multiple endocrine neoplasia type 1 (MEN1) represents a unique possibility to study early neoplasms and their potential precursor lesions.
Thomas Rudolph   +38 more
core   +2 more sources

Multiple endocrine neoplasia type 1 (MEN1)

open access: yesEuropean Journal of Cancer, 1994
Multiple endocrine neoplasia (1–3) is characterized by the occurrence of tumors involving two or more endocrine glands within a single patient. The disorder has previously been referred to as multiple endocrine adenopathy (MEA) or the pluriglandular syndrome.
Pang, J, Thakker, R
openaire   +3 more sources

Multiple electrolyte disturbances as the presenting feature of multiple endocrine neoplasia type 1 (MEN-1)

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2022
A 49-year-old teacher presented to his general physician with lethargy and lower limb weakness. He had noticed polydipsia, polyuria, and had experienced weight loss, albeit with an increase in central adiposity.
Adrian Po Zhu Li   +8 more
doaj   +1 more source

Multiple Endocrine Neoplasia Type 2

open access: yes, 2017
Multiple endocrine neoplasia type 2 (MEN2) is a rare autosomal dominant disorder that predisposes patients to medullary thyroid cancer (MTC), pheochromocytoma (PHEO), and primary parathyroid hyperplasia (PHPT).
Eduardo A. Perez   +3 more
core   +1 more source

Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report

open access: yesThoracic Cancer, 2023
Thymic neuroendocrine tumors associated with multiple endocrine neoplasia are only defined as carcinoid and are not associated with large‐cell neuroendocrine carcinoma (LCNEC).
Shuntaro Hiro   +15 more
doaj   +1 more source

Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome–Related Skin Tumors

open access: yesDiagnostics, 2022
Non-endocrine findings in patients with MEN1 (multiple endocrine neoplasia) syndrome also include skin lesions, especially tumor-type lesions. This is a narrative review of the English-language medical literature including original studies concerning ...
Livia-Cristiana Băicoianu-Nițescu   +4 more
doaj   +1 more source

SYNDROME OF MULTIPLE ENDOCRINE NEOPLASIA OF TYPE 1: CLINICAL CASE

open access: yesŽurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2019
Syndrome of multiple endocrine neoplasia of type 1 (MEN type 1, Vermer's syndrome) is a group of heterogeneous hereditary diseases whose pathogenesis is based on hyperplasia or tumoral transformation of several endocrine glands.
Gulinskaya O. V.   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy